GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells

Published:2018-06 Issue:3 Volume:11 Page:786-793
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Shan Jinshuai,Liu Yang,Wang Yukun,Li Yimiao,Yu Xiaochun,Wu Chen

Funder

National Natural Science Foundation of China

Returned Overseas Chinese Scholars of Hebei Province

Hundreds of outstanding talent innovation projects in Hebei Province

Natural Science Foundation of Hebei province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Multidrug resistance: physiological principles and nanomedical solutions;Kunjachan;Adv Drug Deliv Rev,2013

2. Roles of multidrug resistance genes in breast cancer chemoresistance;Kuo;Adv Exp Med Biol,2007

3. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients;Taheri;Genet Mol Res,2010

4. Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy;Patwardhan;Biochem Pharmacol,2010

5. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells;Donmez;Biomed Pharmacother,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential biomarkers in the peripheral blood of neonates with bronchopulmonary dysplasia using WGCNA and machine learning algorithms;Medicine;2024-01-26

2. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma;Aging;2024-01-19

3. Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer;Cancer Reports;2023-11-07

4. Mucin Glycans: A Target for Cancer Therapy;Molecules;2023-10-11

5. Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells;Frontiers in Oncology;2023-08-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3